A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

ClinicalTrials.gov ID: NCT07008118

Public ClinicalTrials.gov record NCT07008118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-Label, Multicenter Study of INCA035784 in Participants With Myeloproliferative Neoplasms

Study identification

NCT ID: NCT07008118
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Incyte Corporation; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Myeloproliferative Neoplasms

Interventions

INCA035784 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2025
Primary completion: Mar 13, 2028
Completion: Dec 13, 2029
Last update posted: Jul 21, 2026

2025 – 2029

United States locations

U.S. sites: 12
U.S. states: 11
U.S. cities: 12

Facility	City	State	ZIP	Site status
Mayo Clinic Hospital	Phoenix	Arizona	85054	Recruiting
Stanford University	Palo Alto	California	94304	Recruiting
Colorado Blood Cancer Institute	Denver	Colorado	80218	Recruiting
Mayo Clinic-Florida	Jacksonville	Florida	32224	Recruiting
University of Chicago Medical Center	Chicago	Illinois	60637	Not yet recruiting
Johns Hopkins University	Baltimore	Maryland	21287	Recruiting
Icahn School of Medicine At Mount Sinai	New York	New York	10029	Recruiting
University of North Carolina At Chapel Hill	Chapel Hill	North Carolina	27514	Recruiting
South Austin Medical Center	Austin	Texas	78704	Recruiting
University of Texas Southwestern Medical Center Harold C Simmons Comprehensive Cancer Center Blood	Dallas	Texas	75235	Recruiting
Huntsman Cancer Institute At University of Utah	Salt Lake City	Utah	84112	Recruiting
Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07008118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 21, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07008118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →